CID 155801669

Microviridin n9

Structural Information

Molecular Formula
C105H147N25O33
SMILES
C[C@@H]1[C@@H](C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)C[C@H](NC(=O)[C@@H]3CCC(=O)OC[C@@H](C(=O)N[C@@H](CC(=O)O1)C(=O)N[C@H](C(=O)N3)CC(C)C)NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC2=O)CC5=CC=CC=C5)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)CC6=CC=C(C=C6)O)NC(=O)[C@H](CC7=CNC8=CC=CC=C87)NC(=O)[C@@H]9CCCN9C(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)N
InChI
InChI=1S/C105H147N25O33/c1-50(2)41-67-91(147)114-65-33-36-80(140)162-49-73-96(152)120-71(94(150)118-67)46-81(141)163-55(8)85(101(157)122-68(42-57-27-29-59(133)30-28-57)92(148)113-62(88(144)123-72(43-56-19-10-9-11-20-56)102(158)129-39-17-25-74(129)98(154)124-73)23-14-15-37-109-76(134)45-70(119-89(65)145)93(149)117-66(104(160)161)24-16-38-110-105(107)108)128-95(151)69(44-58-47-111-61-22-13-12-21-60(58)61)121-97(153)75-26-18-40-130(75)103(159)82(51(3)4)126-90(146)64(32-35-79(138)139)116-99(155)83(53(6)131)125-77(135)48-112-87(143)63(31-34-78(136)137)115-100(156)84(54(7)132)127-86(142)52(5)106/h9-13,19-22,27-30,47,50-55,62-75,82-85,111,131-133H,14-18,23-26,31-46,48-49,106H2,1-8H3,(H,109,134)(H,112,143)(H,113,148)(H,114,147)(H,115,156)(H,116,155)(H,117,149)(H,118,150)(H,119,145)(H,120,152)(H,121,153)(H,122,157)(H,123,144)(H,124,154)(H,125,135)(H,126,146)(H,127,142)(H,128,151)(H,136,137)(H,138,139)(H,160,161)(H4,107,108,110)/t52-,53+,54+,55+,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,82-,83-,84-,85-/m0/s1
InChIKey
BUCFGLPCTVELLO-YNVQRWCBSA-N
Compound name
(4S)-4-[[(2S,3R)-2-[[(2S)-2-aminopropanoyl]amino]-3-hydroxybutanoyl]amino]-5-[[2-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(1S,4S,10S,13S,19S,22S,25S,29R,30S,33S,43S)-4-benzyl-43-[[(1S)-4-carbamimidamido-1-carboxybutyl]carbamoyl]-33-[(4-hydroxyphenyl)methyl]-29-methyl-22-(2-methylpropyl)-2,5,11,16,21,24,27,31,34,41,45,47-dodecaoxo-15,28-dioxa-3,6,12,20,23,32,35,40,44,46-decazatetracyclo[17.16.10.213,25.06,10]heptatetracontan-30-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-5-oxopentanoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

2286.0593 Da
Monoisotopic Mass

-6.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2287.0666 299.0
[M+Na]+ 2309.0485 291.6
[M-H]- 2285.0520 298.3
[M+NH4]+ 2304.0931 293.1
[M+K]+ 2325.0225 285.6
[M+H-H2O]+ 2269.0566 269.7
[M+HCOO]- 2331.0575 291.8
[M+CH3COO]- 2345.0732 292.1
[M+Na-2H]- 2307.0340 319.9
[M]+ 2286.0588 273.8
[M]- 2286.0598 273.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.